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The aim of this study was to identify predictive factors and develop a model to
assess individualized risk of postnatal surgical intervention in patients with antenatal
hydronephrosis. This is a retrospective cohort study of 694 infants with prenatally
detected congenital anomalies of kidney and urinary tract with a median follow-up time
of 37 months. The main event of interest was postnatal surgical intervention. A predictive
model was developed using Cox model with internal validation by bootstrap technique.
Of 694 patients, 164 (24%) infants underwent surgical intervention in a median age of
7.8 months. Predictors of the surgical intervention in the model were: baseline glomerular
filtration rate, associated hydronephrosis, presence of renal damage and the severity
of renal pelvic dilatation. The optimism corrected c statistic for the model was 0.84
(95%CI, 0.82–0.87). The predictive model may contribute to identify infants at high risk
for surgical intervention. Further studies are necessary to validate the model in patients
from other settings.
Keywords: congenital anomalies of kidney and urinary tract, prenatal diagnosis, antenatal hydronephrosis,
surgical intervention, predictive model
INTRODUCTION
Antenatal hydronephrosis (ANH) is one of the most common birth defects and is a surrogate
marker of potential congenital renal anomalies (1, 2). Congenital anomalies of the kidney and
urinary tract (CAKUT) comprise a wide phenotypic spectrum and are important causes of kidney
morbidity and themost frequent cause of chronic kidney disease (CKD) and end-stage renal disease
in infants and young children (3–5).
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The prenatal detection of CAKUT has permitted a refinement
of the management of these conditions (6–11). Nevertheless, in
spite of the continuous advances in the understanding of the
genetic basis and outcomes of CAKUT, there are still many
controversies regarding postnatal evaluation and management
of infants with ANH. Consequently, taken into account the
heterogeneity of CAKUT, there is an understandable little
consensus about the best approach for these patients (12). In this
setting, a relevant issue concerning the management of CAKUT
is to establish a consistent approach to discern which patients
would benefit from surgical intervention and which may be best
assisted by continued surveillance (2, 13). Retrospective cohort
studies have suggested some predictive factors for surgery or
for spontaneous resolution of renal pelvic dilatation (14, 15),
including the magnitude of renal pelvic diameter, the Society
of Fetal Urology (SFU) grading system, renal parenchyma-to-
hydronephrosis area ratio, renal cortical thickness, and renal
function on renal scintigraphy (16–18).
We have previously described the clinical course of children
with prenatally detected CAKUT and we identified variables
that are possible predictors of progression to CKD (5, 19). The
aim of this retrospective cohort study was to identify potential
predictive factors and to develop a model to assess individualized
risk of postnatal surgical intervention in patients with antenatal
detected CAKUT.
PATIENTS AND METHODS
Patients
All infants with diagnosis of CAKUT (n = 819) admitted at
the Pediatric Nephrology Unit (Hospital das Clínicas, Federal
University of Minas Gerais (UFMG), Brazil) from 1987 to
2013 were followed-up. Patients with aneuploidy, multiple
malformations, neurogenic bladder or loss of follow-up soon
after the birth were excluded (n= 125). In total, 694 infants were
included in the analysis.
Clinical Protocol
During the 25 years of this study, the clinical protocol for the
management of infants with perinatal diagnosis of CAKUT has
inevitably evolved. In the first decade of the study, infants were
investigated according to a comprehensive systematic protocol.
Briefly, all patients with anterior posterior renal pelvic diameter
(APRPD)≥5mmwere placed on prophylactic antibiotics at birth
and submitted to an extensive imaging protocol, including renal
ultrasonography (RUS), voiding cystourethrogram (VCUG), and
renal scintigraphy. After 2000, we developed a more tailored
clinical protocol, based mainly on the severity of the renal pelvic
dilatation (20). All infants underwent VCUG within 3 months of
life until 2009. Since then, VCUGhas been indicated for a selected
subgroup of patients with fetal or postnatal APRPD > 10mm
and or ureter dilatation (21). Renal scintigraphy (Tc−99mDMSA
and Tc−99mDTPA) was performed after the first month of life for
patients with APRPD ≥10mm (22). Antibiotic prophylaxis was
started on the first postnatal day and maintained in accordance
with the postnatal diagnosis (23).
Follow-Up Protocol
After initial clinical and imaging evaluation, RUS scans, clinical
visits, and laboratory reviews (including urine culture and
serum creatinine) were scheduled at 6-month intervals. In short,
the clinical approach consisted of full physical examination,
including evaluation of anthropometric measurements and
blood pressure performed at 6-month intervals. Urine
cultures were obtained at each 6-month follow-up visit,
and it was recommended that urine samples be collected
during any unexplained febrile episode or in the presence of
urinary symptoms.
Outcome
The main event of interest was defined as the time from birth
until the first surgical intervention.
Candidate Predictors
The following variables at baseline were considered in the
analysis: gender, age, serum creatinine, the estimative of
glomerular filtration rate (eGFR) based on conventional or
modified Schwartz formulas (24, 25), oligohydramnios, presence
of other ultrasonographic urinary tract alterations besides
antenatal hydronephrosis (associated hydronephrosis), renal
pelvic dilatation (RPD) laterality (unilateral vs. bilateral),
presence of renal damage (RD) on Tc−99mDMSA scan and
APRPD. Combined data obtained by VCUG, renal scan and
sequential RUS were considered for the diagnosis of urinary
tract anomalies. The absence of any recognized uropathy was
classified as idiopathic hydronephrosis. Isolated hydronephrosis
was defined as the presence of APRPD ≥5mm without any
other alterations of the urinary tract. Associated hydronephrosis
was defined as the presence of APRPD >5mm combined with
other alterations, including megaureter and megacystis. When
bilateral renal pelvic dilation was present, the largest APRPD
was considered for analysis. Presence of RD on Tc−99mDMSA
scan was classified as none, unilateral and bilateral, when there
was renal scarring and/or parenchymal atrophy in none, one
or both kidneys, respectively. The diagnosis of oligohydramnios
was based on amniotic fluid index (26). Since creatinine
measurements were made using the Jaffemethod until November
2011 in our institution, glomerular filtration rate (eGFR) was
estimated by the conventional Schwartz formula (24) for data
obtained until this period. After November 2011, creatinine was
measured using the isotope dilution mass spectrometry (IDMS)
traceable method and, for this reason, we adopted the modified
Schwartz formula (25).
Statistical Analysis and Development of
the Risk Prediction Model
The values are expressed as medians and interquartile ranges
(IQs) or frequencies when appropriate. Survival analyses were
performed by the Kaplan–Meier method (KM) and by the Cox
proportional hazards model to evaluate time until the occurrence
of the event. Differences between dichotomous variables were
assessed by the two-sided log-rank test. The Cox proportional
hazards model was applied to identify variables that were
independently associated with the occurrence of the event.
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Variables selected for multivariable analyses were used to build
a final model after discarded any violation of proportionality
assumptions. Cox proportional hazards regression analysis was
used to assess the association between the candidate predictors
and the occurrence of surgery. Hazard ratios for continuous
variables were given for the 75 percentile vs. 25 percentile of the
variable. Using a backward elimination strategy with p < 0.1, the
strongest prognostic factors were included in the finalmodel (27).
Missing values for candidate predictors were filled in with
multiple imputation (MI) procedure. Each missing value was
imputed five times. Imputed values were drawn from the
predictive distribution in an imputation model that included
all candidate predictors and the outcome (time to surgery). MI
resulted in five complete datasets, which were analyzed with
standard complete data methods. The results were combined to
produce overall estimates and standard errors that reflect missing
data uncertainty (28).
When prediction models are developed in relatively small
samples, they may be overfitted and may show optimistic
performance. To adjust for overfitting and optimistic
performance of the model, we used bootstrap resampling
for internal validation. One hundred bootstrap samples were
drawn with replacement; a prognostic model was developed in
each sample; and the performance was evaluated in the bootstrap
sample and in the original sample (29). The model was presented
as a nomogram where each predictor could be judged for its
relative importance by the number of points attributed over the
range of the predictor (30). Statistical analyses were performed
with R software version 2.13.1 (R Foundation for Statistical
Computing, Vienna, Austria) and SPSS version 18.0 (SPSS,
Inc., Chicago).
RESULTS
Themain baseline clinical characteristics of 694 patients included
in the analysis are summarized in Table 1. The median follow-up
time of the cohort was 37 months (Interquartile range (IQ), 14–
85 months). A total of 164 (24%) patients underwent surgery at a
median age of 7.8 months (IQ, 2.4–16.1 months). The majority
of patients were males, considering the entire CAKUT group
(65%) as well the subgroup of children who underwent surgical
intervention (76%).
Table 2 shows the baseline findings and the association
between patient characteristics and postnatal surgical
intervention. In univariate analysis, the following variables
were associated with the outcome: age, serum creatinine, eGFR,
oligohydramnios, associated hydronephrosis, laterality, presence
of RD, and APRPD.
After adjustment by the Cox model, four predictors had
strong effects and remained in the final model: eGFR, associated
hydronephrosis, renal damage, and severity of renal pelvic
dilatation (Table 3). Figures 1A–E shows the Kaplan-Meier
survival curves for the predictive variables of postnatal surgical
intervention. The uniform shrinkage factor estimated with
bootstrapping was 1.0. The c statistic was 0.81 (95% CI 0.77–
0.83), after correction for optimism.
TABLE 1 | Baseline clinical characteristics of 624 infants included in the analysis.
N (%)
GENDER
Male 453 (65.3)
Female 241 (34.7)
LATERALITY—FETAL US
Unilateral 411 (59.3)
Bilateral 283 (40.7)
PERIOD
1989–1999 174 (25.0)
2000–2013 520 (75.0)
POSTNATAL DIAGNOSIS
Idiopathic hydronephrosis 277 (39.9)
Ureteropelvic obstruction junction 122 (17.6)
Multicystic dysplastic kidney 97(14)
Vesicoureteral reflux 57 (8.2)
Primary megaureter 40 (5.8)
Posterior urethral valves 26 (3.7)
Ureterocele 20 (2.9)
Hypodysplastic kidney 14 (2.0)
Prune-belly syndrome 6 (0.9)
Others 35 (5.0)
The predictivemodel is presented as nomogram to provide the
risk that a patient undergoes surgical intervention within 2 years
(Figure 2). To use the nomogram, a line from each predictor
value needs to be drawn upwards to the point axis. Then, the
points corresponding to the predictor values need to be added
and the result to be located to the Total Points axis. A line from
the total points value to the axis for 2 years risk of surgery needs
to be drawn to find the risk of surgery within 2 years of follow-up.
The formula with shrunk coefficients used to calculate the
individual absolute risks of postnatal surgical intervention was
calculated as follow:
risk(t) = [1− S0 (t)
exp(lp)]× 100%, where
lp=− 0.012× eGFR+ 0.62× associated hydronephrosis+0.83
× RD uni + 1.37 × RD bi + 0.037 × APRPD; S0(12) = 0.962;
S0(36)= 0.920; S0(60)= 0.910.
For example, a child with eGRF of 40 ml/min/1.73 m2 (10
points), associated hydronephrosis (5 points), bilateral RD (9
points), APRPD of 40mm (10 points). The total of 34 points
corresponds to a more than 90% of risk of surgical intervention
before 2 years age.
Finally, the sample was divided into three risk scores: low-
risk (<20 points), medium-risk (20–28 points) and high-risk
(≥29 points). The risk of surgical intervention at 2 years of
age was estimated as 10% for patients assigned to the medium-
risk group and 53% for patients of the high-risk group (P <
0.001, Figure 3). Figure 4 shows the calibration plots for the
model of risk prediction during 2 years of follow-up. The model
showed good calibration for all risk categories although with a
slight overestimated risk of surgical intervention for low and
medium-risk groups.
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TABLE 2 | Patients’ characteristics and association with surgical intervention.
Characteristics Unit or
category
Surgical intervention Hazard ratio
(95%CI)
Yes
N = 164
No
N = 530
Gender Male/female 124 (76%) 329 (62%) 1.2 (0.82–1.6)
Age at admission Months 1.1 (0.19–2.9) 2.2 (0.82–4.9) 1.1 (1.0–1.2)#
Plasma creatinine mg/dl 0.50
(0.39–0.73)
0.36
(0.30–0.50)
1.2 (1.1–1.2)
eGRF ml/min/
1.73 m²
52(31–75) 71 (51–92) 2.2 (1.7–2.9)#
Oligohydramnios* Yes/no 14 (8.5%) 12 (2.3%) 3.7 (2.1–6.4)
Assoc. hydro** Yes 92 (61%) 160 (31%) 3.0 (2.2–4.2)
Laterality Uni/bilateral 63 (45%) 220 (43%) 1.2 (0.83–1.6)
Renal damage*** None 55 (38%) 200 (69%) Reference
Unilateral 75 (52%) 84 (28%) 2.6 (1.9–3.7)
Bilateral 13 (10%) 9 (3%) 4.3 (2.3–7.8)
APRPD**** mm 20(13-29) 8(6–12) 1.5 (1.4–1.7)
eGRF, estimated glomerular renal function; APRPD, anteroposterior renal pelvis dilatation;
RPD, renal pelvic dilatation; 95%CI, 95% confidence interval. Values are given as number
(percentage of observed total) or median (25–75 percentile), unless stated otherwise;
Hazard ratios for continuous variables are given for the 75 percentile vs. the 25 percentile.
*missing, 426; **missing, 25; ***missing, 258; ****missing, 85. #risk is higher for lower
predictor values.
TABLE 3 | Multivariable association of the selected predictive factors for surgical
intervention.
Predictive factor Unit or category Hazard ratio [95% CI]
eGFR 47 vs. 90 ml/min/1.73 m² 1.7 (1.3–2.2)
Associated Hydro. Yes/no 1.9 (1.3–2.6)
Renal damage Unilateral 2.3 (1.6–3.2)
Bilateral 4.0 (2.1–7.4)
APRPD 16 vs.7mm 1.4 (1.3–1.5)
Hazard ratios for continuous variables are given for the 75 percentile vs. the 25
percentile. eGRF, estimated glomerular renal function; APRPD, anterior posterior renal
pelvis diameter; RPD, renal pelvic dilatation.
DISCUSSION
In this cohort study, we evaluated predictive factors of surgical
intervention in a large cohort of children with CAKUT enrolled
at a tertiary center between 1987 and 2013. Overall, about
a quarter of these patients underwent surgical intervention.
Nevertheless, children born after 2000 had surgical intervention
less frequently (15%). After adjustment by Cox multivariate
model, four variables remained as predictive factors for surgical
intervention: eGFR, associated hydronephrosis, presence of RD
on baseline DMSA scan and the APRPD. Finally, we combined
the factors in a clinical predictive model for surgical intervention
with a good predictive performance.
CAKUT is a heterogeneous and complex group of diseases
associated with UTI, CKD and hypertension in children (31–34).
Antenatal ultrasonography reveals an increasing number of
renal anomalies in otherwise uncomplicated pregnancies. Thus,
antenatal screening creates a clinical group of patients, often
asymptomatic, for whom postnatal management and follow-
up are required (35, 36). The main goal of fetal screening
for uropathies is to prevent complications. In this regard, the
majority of CAKUT is non-surgically managed, but, in some
cases, surgery will be necessary to avoid renal parenchyma
damage and recurrent urinary tract infections. Currently,
nonsurgical management of CAKUT should be considered
whenever possible for infants with ANH. Nevertheless, there
are still controversies regarding the best postnatal approach for
many uropathies (34, 36–38). Unnecessary interventions must be
avoided, but late procedures may enhance the risk of infection
and renal parenchymal loss (34). However, the ability to define
which children will resolve their condition or will benefit from
a surgical procedure remains elusive. So far, a single reference
test is not available to define which patient and at what time
will need surgery. Early identification of patients at high risk
for surgical procedures may be helpful for medical decisions
and may decrease unnecessary interventions in low risk patients
(37, 39). Moreover, prenatal diagnosis studies have shown
that families are worried irrespective of suspicious of a mild
hydronephrosis or of a severe malformation. The information
about fetal malformation findings during the ultrasound
examination often comes unexpectedly, and families may not
necessarily receive at the time of diagnosis any conclusive
statement on the prognosis (40). Thus, clinical predictive models
can enhance the ability of the health team to manage this
stressful situation.
As expected, in our series, patients admitted at the first
period of the study (1983–1999) had a greater probability
to undergo surgical intervention (RR = 4.2, 95%CI, 2.8–
6.3). The prenatal detection of CAKUT has permitted a
refinement of the management of these conditions. For
instance, it has been clearly demonstrated by longitudinal
studies that many children with partial ureteropelvic or
ureterovesical junction obstruction will spontaneously resolve
their hydronephrosis (31, 41). Consequently, our findings
probably reflected the shift on the management of asymptomatic
infants with antenatal hydronephrosis. Currently, there
is a consensus that a nonsurgical management should be
considered whenever possible for infants with antenatal
hydronephrosis (13, 36, 37).
Previous studies have also identified predictive factors of
surgical intervention in patients with CAKUT (15, 39) For
instance, Nef et al. (39) reported impaired renal function,
oligohydramnios and postnatal bilateral renal anomalies as
potential predictors of surgical intervention. The latter two were
also associated with surgical intervention in the current cohort,
but not included in the final model.
Post-natally, the most commonmeasurements of urinary tract
dilation (UTD) are APRPD and the SFU grading system (8). An
accurate description of the degree of UTD is important because
its severity can guide further management. Severe fetal UTD is
commonly associated with significant postnatal uropathy, often
requiring surgery (42). Unfortunately, due to the retrospective
design of our study, we were not able to use the SFU system
as a possible predictive factor in the model. Nevertheless, the
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FIGURE 1 | Kaplan Meier estimates the risk of surgical intervention stratified according to (A) renal function at baseline; (B) associated hydronephrosis; (C) renal
damage; (D) renal pelvic dilatation; and (E) period of admission.
FIGURE 2 | Nomogram for predicting 2 years risk of surgery based on 5 predictors; estimated glomerular renal function in mL/min/1.73 m2 (eGFR), associated
hydronephrosis, renal damage, APRPD (anteroposterior renal pelvis diameter) in mm, period of admission (before 2000); 2-year risk of surgery.
magnitude of renal pelvic dilatation was an independently
predictive factor for surgical intervention in the final model.
A number of studies have shown the good performance of
measurement of APRPD as a predictor of the severity of the
renal anomaly, especially in the context of the isolated antenatal
hydronephrosis (15, 16, 22). Recently, Arora et al. (14) reported
a prospective single-center study including 122 renal units with
ANH. A multivariate analysis revealed APRPD and preoperative
differential renal function on renal scintigraphy as the only
independent predictors for surgical intervention. As expected,
in our series, renal damage on renal scintigraphy was also a
predictor of surgical intervention. Renal scintigraphy has been
the most commonly used modality to determine the presence of
upper urinary tract obstruction in infants with ANH. However,
the diagnostic accuracy of diuretic renal scintigraphy has been
reported to be highly variable. In a notable review, Ismaili and
Piepsz (43) outlined the advances, pitfalls, and difficulties in
the interpretation of renography for the evaluation of upper
tract obstruction in infants. Interestingly, in a well-designed
study, the same group concluded that diuretic renal scintigraphy
should only be performed in patients with APRPD more
than 30mm, major calyceal dilatation, and/or parenchymal
thinning (44).
Some clinical and methodological considerations should
be taken into account in evaluating our findings. From the
methodological point of view, we did not validate this risk
prediction instrument in an independent cohort. External
validation is important, because accurate predictions in our
cohort do not necessarily guarantee good accuracy in other
patients (45). Missing data are a common problem in all
retrospective cohort studies. We have addressed this problem
by using multiple imputations that have the advantage of not
ignoring observations with incomplete information and, at the
same time, reflecting the uncertainty of the imputation process.
Regarding methodological clinical aspects, a weakness is that the
medical team decided the surgical intervention based mainly
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FIGURE 3 | Kaplan Meier plot for risk of surgery according to risk category. Low-risk category, <20 points; Medium-risk category, 20–28 points; High-risk category,
29+ points.
FIGURE 4 | Agreement between predicted 2-year risk of surgery and
observed risk.
on the variables in the model. This fact would imply that we
modeled the decision making of the surgery rather than the
“real” need of surgery. However, it must be pointed out that
the children who did not undergo surgery had a long follow-
up time in our series and the medical treatment was shown as
a safe approach for these patients. Another fragility is that false
positive cases, i.e., children who underwent surgery but was not
benefited by it, could not be identified due to the observational
design of our study. In addition, our sample contains mixed
phenotypes of CAKUT, including both isolated hydronephrosis
and more complex entities, which may interfere with accurate
predictions. On the other hand, some features of our study
may increase the strength of our findings, including the large
dataset collected over many years, the length of the follow-up
time, and the management by the same medical team using a
standardized protocol.
In summary, we have developed a clinical predictive
model of surgical intervention in children with CAKUT.
The magnitude of renal pelvic dilatation, renal function at
baseline, presence of associated hydronephrosis and of renal
damage are independent predictors of surgical intervention
during follow-up. This clinical predictive model, if confirmed
in future studies and after external validation, may help the
medical team to identify infants with antenatal hydronephrosis
at high-risk for surgical intervention during the first years
of life.
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